Abstract
Objective
Methods
Results
Conclusion
ACKNOWLEDGMENTS
References
Table 1.
Variable | Value (n=23) |
---|---|
Sex, M : F | 15 : 8 |
Age at admission (years) | 68.9 (39–94) |
Initial symptom | |
Pain (axial or extremity) | 12 (52.2) |
Fever | 6 (26.1) |
Neurologic deficit | 3 (13.0) |
Miscellaneous | 2 (8.7) |
Time from symptom onset to admission (days) | 10.3 (0–120) |
Comorbidity and past medical history | |
Hypertension | 12 (52.2) |
Diabetes mellitus | 10 (43.5) |
Stroke history | 6 (26.1) |
Heart problem | 5 (21.7) |
Chronic kidney disease | 3 (13.0) |
Malignancy history | 3 (13.0) |
Concomitant infection | 12 (52.2) |
Invasive spinal intervention history* | |
Injection or acupuncture | 6 (26.1) |
Open spine surgery | 1 (4.3) |
Vertebroplasty+injection | 1 (4.3) |
Time from admission to diagnosis (days) | |
Bacteremia by blood culture† | 1.7 (0–19) |
Radiologic diagnosis by MRI | 8.4 (0–59) |
Time from admission to operation (days) | 16.6 (0–66) |
Microbiological data | |
Positive peripheral blood culture | 23 (100.0) |
Positive surgical specimen culture | 15 (65.2) |
Radiologic data (from immediate preoperative MRI) | |
Cervical spine abscess | 4 (17.4) |
Thoracic spine abscess | 2 (8.7) |
Thoraco-lumbar spine abscess | 2 (8.7) |
Lumbar spine abscess | 11 (47.8) |
Lumbo-sacral spine abscess | 4 (17.4) |
Osteomyelitis | 18 (78.3) |
Psoas or paraspinal abscess | 15 (65.2) |
Size (vertebral bodies) | 2.9 (1–6) |
Severity of thecal sac compression‡ | |
Mild | 5 (21.7) |
Moderate | 12 (52.2) |
Severe | 6 (26.1) |
Location | |
Ventral | 14 (60.9) |
Dorsal | 4 (17.4) |
Both | 5 (21.7) |
Recurrence | 1 (4.3) |
Mortality | 3 (13.0) |
Table 2.
No. | Sex/age* | Initial symptom |
Time to† (days) |
Comorbidity | Past medical history |
Neurologic status‡ (mRS) |
Mode of Op. |
Duration of antibiotics (days) |
|||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adm | Dx | Op | Adm | Preop | Final | Preop. | Postop. | ||||||
1 | M/76 | Fever | 2 | 1 | 32 | DM | Prostate Ca. | 1 | 1 | 0 | Lami | 32 | 25 |
2 | M/70 | Weakness | 7 | 0 | 5 | CABG, CVA | 2 | 2 | 0 | Lami | 0 | 76 | |
3 | F/58 | Back pain | 7 | 0 | 1 | 0 | 0 | 0 | Lami | 0 | 54 | ||
4 | F/64 | Back pain | 21 | 0 | 27 | HT | 0 | 0 | 0 | Lami | 27 | 44 | |
5 | F/75 | Back pain | 6 | 0 | 4 | DM, MI | CVA | 1 | 3 | 6 | Lami | 4 | 38 |
6 | M/53 | Fever | 2 | 25 | 30 | DM, dementia | CVA | 0 | 0 | 0 | Lami | 30 | 50 |
7 | F/76 | Back pain | 7 | 7 | 11 | HT | 3 | 3 | 3 | Lami | 0 | 64 | |
8 | M/68 | Back pain | 0 | 59 | 66 | DM, HT | 0 | 0 | 0 | Lami | 46 | 23 | |
9 | M/85 | Back pain | 5 | 0 | 8 | HT, hypothyroidism | 4 | 4 | 6 | Lami | 8 | 23 | |
10 | M/65 | Back pain | 120 | 1 | 2 | DM, HT | 2 | 2 | 0 | Retro | 0 | 58 | |
11 | F/79 | Fever | 2 | 12 | 23 | HT, Af, MI | CVA, Rectal Ca. | 4 | 4 | 0 | Lami | 21 | 72 |
12 | M/59 | Fever | 2 | 7 | 9 | HT | 3 | 3 | 0 | Lami | 9 | 95 | |
13 | M/52 | Back pain | 2 | 20 | 27 | 0 | 0 | 0 | Lami | 27 | 23 | ||
14 | F/71 | Back pain | 6 | 28 | 43 | DM, HT, CKD | AVR, CVA | 0 | 0 | 0 | Lami | 47 | 23 |
15 | F/90 | Dyspnea | 1 | 3 | 14 | HT | 0 | 0 | 0 | Lami | 7 | 36 | |
16 | M/81 | Weakness | 0 | 0 | 0 | DM | 4 | 5 | 3 | Lami | 0 | 49 | |
17 | F/55 | Back pain | 7 | 1 | 2 | 2 | 2 | 0 | Lami | 1 | 67 | ||
18 | M/39 | Melena | 3 | 2 | 7 | Mental retardation | 0 | 0 | 0 | Lami | 7 | 68 | |
19 | M/72 | Weakness | 7 | 0 | 2 | CVA | 5 | 5 | 5 | Corp | 2 | 48 | |
20 | M/67 | Back pain | 4 | 0 | 1 | DM, HT, CKD | Kidney TPL | 2 | 2 | 0 | Lami | 0 | 45 |
21 | M/94 | Fever | 2 | 0 | 26 | DM, HT | Gastric Ca. | 0 | 0 | 0 | Lami | 26 | 64 |
22 | M/83 | Fever | 0 | 27 | 29 | DM, HT, ESRD, Af | 2 | 5 | 6 | Lami | 29 | 68 | |
23 | M/53 | Neck pain | 24 | 0 | 12 | 2 | 3 | 0 | Corp | 9 | 56 |
† Adm: time from initial symptom onset to admission, Dx : time from admission to radiologic diagnosis of epidural abscess using MRI, Op : time from admission to surgery for abscess removal.
‡ Adm : at admission, Preop : immediate preoperative, Final : at last follow-up. mRS : modified Rankin scale, Op. : operation, Preop. : duration of preoperative antibiotic treatment, Postop. : duration of postoperative antibiotic treatment, M : male, DM : diabetes mellitus, Ca. : cancer, Lami : laminectomy and abscess removal, CABG : coronary artery bypass graft, CVA : cerebrovascular accident, F : female, HT : hypertension, MI : myocardial infarction, Retro : retroperitoneal approach and abscess removal, Af : atrial fibrillation, CKD : chronic kidney disease, AVR : atrial valve replacement, Corp : corpectomy and abscess removal, TPL : transplantation, ESRD : end-stage renal disease
Table 3.
No. | Previous intervention* | Concomitant infection |
Identified organism |
|
---|---|---|---|---|
Peripheral blood | Surgical specimen | |||
1 | S. agalactiae | No growth | ||
2 | lumbar fusion | MRSE | MRSE | |
3 | SAG+S. capitis | SAG | ||
4 | Injection | SAG | No growth | |
5 | UTI† | MSSA | MSSA | |
6 | Scrotal abscess†/UTI† | MRSA | MRSA | |
7 | MSSE+S. caprae | No growth | ||
8 | Scapular abscess | MRSA | No growth | |
9 | MSSA | MSSA+S. warneri | ||
10 | VP/injection | E. faecalis | E. faecalis | |
11 | Acupuncture | Urosepsis† | E. coli | E. coli |
12 | Injection | E. coli | E. coli | |
13 | Pl. eff.†/septic arthritis | MSSA | No growth | |
14 | Inf. endocarditis | MRSE | No growth | |
15 | Injection | Inf. endocarditis | E. faecalis | No growth |
16 | Injection | MSSA | MSSA | |
17 | UTI† | MSSA | MSSA | |
18 | MSSA | MSSA | ||
19 | UTI† | MSSA | MSSA | |
20 | S. agalactiae | S. agalactiae | ||
21 | Injection | UTI† | MRSA+MSSA | No growth |
22 | AV infection†/UTI† | MRSA | MRSA | |
23 | UTI† | MSSA | MSSA |
S. agalactiae : Streptococcus agalactiae-(group B), MRSE : methicillin-resistant Staphylococcus epidermidis, SAG : Streptococcus anginosus group, S. capitis : Staphylococcus capitis, UTI : urinary tract infection, MSSA : methicillin-sensitive Staphylococcus aureus, MRSA : methicillinresistant Staphylococcus aureus, MSSE : methicillin-sensitive Staphylococcus epidermidis, S. caprae : Staphylococcus caprae, S. warneri : Staphylococcus warneri, VP : vertebroplasty, E. faecalis : Enterococcus faecalis, E. coli : Escherichia coli, Pl. eff. : pleural effusion, Inf. : infective, AV : arteriovenous graft